2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
US9775839B2 · kind B2 · utility
0Cited by
20References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2015 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | Mar 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain pyrazine-2-carboxamide compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A, B, and X are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.